Efficacy of fludarabine and mitoxantrone (FN) combination regimen in untreated indolent non-Hodgkin's lymphomas
Open Access
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 11 (3) , 363-366
- https://doi.org/10.1023/a:1008388824069
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Fludarabine, cyclophosphamide, and dexamethasone (FluCyD) combination is effective in pretreated low-grade non-Hodgkin's lymphomaAnnals of Oncology, 1999
- Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.Journal of Clinical Oncology, 1998
- Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphomaAnnals of Oncology, 1997
- Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma.Journal of Clinical Oncology, 1996
- Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma.Journal of Clinical Oncology, 1992
- Activity of fludarabine in previously treated non-Hodgkin's low-grade lymphoma: results of an Eastern Cooperative Oncology Group study.Journal of Clinical Oncology, 1992